Skip to main content
. 2023 Sep 27;6(4):463–469. doi: 10.31662/jmaj.2023-0019

Table 1.

Characteristics of COVID-19-Positive Patients Included in the Analysis by Vaccination Status.

Characteristics Overall Number of Vaccinations Completed
None 1 2 3 4
n = 95,329 n = 35,008 n = 730 n = 31,009 n = 26,382 n = 2,200
no. (%)
Sex Male 46,596 (48.9) 18,807 (53.7) 364 (49.9) 15,348 (49.5) 11,176 (42.4) 901 (41.0)
Age category (years) 5-11 13,723 (13.4) 12,606 (30.1) 185 (25.3) 932 (3.0) 0 (0.0) N.A.
12-19 11,867 (11.6) 5,227 (12.5) 127 (17.4) 5,231 (16.9) 1,276 (4.8) 6 (0.3)
20-29 17,096 (16.7) 6,724 (16.1) 158 (21.6) 6,423 (20.7) 3,732 (14.2) 59 (2.7)
30-39 16,182 (15.8) 4,180 (10.0) 102 (14.0) 6,926 (22.3) 4,835 (18.3) 139 (6.3)
40-49 15,491 (15.2) 3,054 (7.3) 66 (9.0) 6,175 (19.9) 5,974 (22.6) 222 (10.1)
50-59 9,027 (8.8) 1,686 (4.0) 43 (5.9) 2,896 (9.3) 4,226 (16.0) 176 (8.0)
60-64 2,895 (2.8) 389 (0.9) 6 (0.8) 719 (2.3) 1,620 (6.1) 161 (7.3)
65+ 9,048 (8.9) 1,142 (2.7) 43 (5.9) 1,707 (5.5) 4,719 (17.9) 1,437 (65.3)
Comorbidities Yes 8,611 (9.0) 2,224 (6.4) 67 (9.2) 3,210 (10.4) 2,945 (11.2) 165 (7.5)
Obesity Yes 7,796 (8.2) 2,146 (6.1) 59 (8.1) 3,702 (11.9) 1,847 (7.0) 42 (1.9)
Pregnancy Yes 533 (0.6) 146 (0.4) 5 (0.7) 265 (0.9) 117 (0.4) 0 (0.0)
Smoking status Yes 6,493 (6.8) 2,396 (6.8) 52 (7.1) 2,968 (9.6) 1,060 (4.0) 17 (0.8)
Vaccine type BNT162b2 only 43,274 (45.4) N.A. 639 (87.5) 25,493 (82.2) 15,973 (60.6) 1,169 (53.1)
mRNA-1273 only 7,966 (8.4) N.A. 78 (10.7) 5,460 (17.6) 2,419 (9.2) 9 (0.4)
Others * 9,081 (9.5) N.A. 13 (1.8) 56 (0.2) 7,990 (30.3) 1,022 (46.5)
Days elapsed since the vaccination Mean (SD) 172.42 (7-538) N.A. 146.71 (7-538) 220.57 (7-511) 128.88 (7-370) 24.27 (7-102)

*Others (vaccine type) indicate that the patient took a combination of different vaccines.